Multiomics medicine in oncology: assessing effectiveness, cost-effectiveness and future research priorities for the molecularly unique individual

Grants

Funding Acknowledgements

B Doble is supported by research scholarships from Monash University. D Thomas, S Fox and P Lorgelly are recipients of a Victorian Government Translational Research Grant through the Victorian Cancer Agency. The funding sources had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review and approval of the manuscript; or decision to submit the manuscript for publication. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.